These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosoma mansoni larvae. Silberstein DS; Dessein AJ; Elsas PP; Fontaine B; David JR J Immunol; 1987 May; 138(9):3042-50. PubMed ID: 3494778 [TBL] [Abstract][Full Text] [Related]
23. A new function for platelets: IgE-dependent killing of schistosomes. Joseph M; Auriault C; Capron A; Vorng H; Viens P Nature; 1983 Jun; 303(5920):810-2. PubMed ID: 6866081 [TBL] [Abstract][Full Text] [Related]
24. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. Wanidworanun C; Strober W J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695 [TBL] [Abstract][Full Text] [Related]
25. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641 [TBL] [Abstract][Full Text] [Related]
26. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection. Pemberton RM; Wilson RA Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008 [TBL] [Abstract][Full Text] [Related]
27. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Owen-Schaub LB; Gutterman JU; Grimm EA Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408 [TBL] [Abstract][Full Text] [Related]
28. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. Wynn TA; Oswald IP; Eltoum IA; Caspar P; Lowenstein CJ; Lewis FA; James SL; Sher A J Immunol; 1994 Dec; 153(11):5200-9. PubMed ID: 7525727 [TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. Kornbluth RS; Edgington TS J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568 [TBL] [Abstract][Full Text] [Related]
30. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activity. Williams ME; Caspar P; Oswald I; Sharma HK; Pankewycz O; Sher A; James SL J Immunol; 1995 May; 154(9):4693-700. PubMed ID: 7722322 [TBL] [Abstract][Full Text] [Related]
32. Coordinated induction of autocrine tumor necrosis factor and interleukin 1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity. Smith DM; Lackides GA; Epstein LB Cancer Res; 1990 Jun; 50(11):3146-53. PubMed ID: 2334910 [TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity of unstimulated and thrombin-activated platelets to human tumour cells. Sagawa T; Tominaga A; Kodama T; Okada M Immunology; 1993 Apr; 78(4):650-6. PubMed ID: 8495982 [TBL] [Abstract][Full Text] [Related]
34. Schistosoma mansoni: protective immunity in IL-4-deficient mice. King CL; Malhotra I; Jia X Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774 [TBL] [Abstract][Full Text] [Related]
35. Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies. Damonneville M; Auriault C; Verwaerde C; Delanoye A; Pierce R; Capron A Clin Exp Immunol; 1986 Aug; 65(2):244-52. PubMed ID: 3098476 [TBL] [Abstract][Full Text] [Related]
36. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni. Moqbel R; Macdonald AJ; Cromwell O; Kay AB Immunology; 1990 Mar; 69(3):435-42. PubMed ID: 2312166 [TBL] [Abstract][Full Text] [Related]